ARNEXAN Trademark

Trademark Overview

On Wednesday, March 10, 2010, a trademark application was filed for ARNEXAN with the United States Patent and Trademark Office. The USPTO has given the ARNEXAN trademark a serial number of 77955358. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2013. This trademark is owned by BIOFARMA. The ARNEXAN trademark is filed in the Pharmaceutical Products category with the following description:

Antidepressants; pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; pharmaceutical preparations for the prevention and treatment of diabetes
arnexan

General Information

Serial Number77955358
Word MarkARNEXAN
Filing DateWednesday, March 10, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2010

Trademark Statements

Goods and ServicesAntidepressants; pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; pharmaceutical preparations for the prevention and treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 16, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuresnes cedex 92284
FR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNeuilly-Sur-Seine 92200
FR

Trademark Events

Event DateEvent Description
Monday, October 28, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 28, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 22, 2013EXTENSION 5 GRANTED
Wednesday, March 20, 2013EXTENSION 5 FILED
Wednesday, March 20, 2013TEAS EXTENSION RECEIVED
Wednesday, September 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 25, 2012EXTENSION 4 GRANTED
Thursday, September 20, 2012EXTENSION 4 FILED
Thursday, September 20, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, March 19, 2012EXTENSION 3 GRANTED
Friday, March 16, 2012EXTENSION 3 FILED
Friday, March 16, 2012TEAS EXTENSION RECEIVED
Thursday, October 20, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 20, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, September 7, 2011EXTENSION 2 GRANTED
Tuesday, September 6, 2011EXTENSION 2 FILED
Wednesday, September 7, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2011TEAS EXTENSION RECEIVED
Friday, March 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, March 9, 2011EXTENSION 1 GRANTED
Wednesday, March 9, 2011EXTENSION 1 FILED
Wednesday, March 9, 2011TEAS EXTENSION RECEIVED
Tuesday, September 21, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2010PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2010NOTICE OF PUBLICATION
Tuesday, June 22, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 22, 2010ASSIGNED TO LIE
Saturday, June 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2010ASSIGNED TO EXAMINER
Tuesday, March 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 13, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

arnexan treatment preparations prevention pharmaceutical diabetes disease alzheimer antidepressants